Teva Sued Over Generic HIV Drug

Law360, New York (August 8, 2011, 7:21 PM EDT) -- ViiV Healthcare Co., a joint venture of GlaxoSmithKline PLC and Pfizer Inc., filed a patent infringement suit against Teva Pharmaceutical Industries Ltd. on Monday in Delaware federal court to stop Teva from making a generic version of HIV drug Epzicom.

ViiV is asking the court to issue an order blocking Israel-based Teva from making a generic version of Epzicom, also known as Kivexa. Teva's proposed generic will infringe a U.S. patent ViiV obtained in 2002, the suit claims.

“ViiV will be irreparably harmed by Teva's infringing...
To view the full article, register now.